ASK REDCHAT ANYTHING ABOUT PHIO PHARMACEUTICALS CORP.
Phio Pharmaceuticals Corp. (NASDAQ: PHIO)
Listen to this Section
$1.13
+0.0150
(
+1.35% )
69.8K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| PH-762DetailsCutaneous squamous cell carcinoma, Melanoma, Metastatic merkel cell carcinoma, Cancer |
Phase 1b |
Market Data
|
| Open |
$1.13 |
| Previous Close |
$1.11 |
| Volume |
69.8K |
| Market Cap |
$12.90M |
| Day Range |
$1.11 - $1.14 |
| 52 Week Range |
$0.81 - $4.19 |
| Shares Outstanding |
11.62M |
| Change % |
+1.35% |
| Net Change |
▲ 0.0150 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2012 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
12,286.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-02-20 |
Sale |
-658.00 |
Kontulis Caitlin |
| 2023-10-03 |
Sale |
-917.00 |
Bitterman Robert J |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 10-q |
Quarterly Reports |
55 |
Nov 13, 2025 |
| 8-k |
8K-related |
15 |
Nov 13, 2025 |
| 8-k |
8K-related |
18 |
Nov 06, 2025 |
| 8-k |
8K-related |
15 |
Nov 03, 2025 |
| 8-k |
8K-related |
15 |
Oct 31, 2025 |
| 4 |
Insider transactions |
1 |
Sep 15, 2025 |
| 4 |
Insider transactions |
2 |
Sep 15, 2025 |
| 4 |
Insider transactions |
2 |
Sep 15, 2025 |
| 4 |
Insider transactions |
2 |
Sep 15, 2025 |
| 4/a |
Other |
1 |
Sep 15, 2025 |